These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10517044

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Value of the combination of oral ondansetron with methylprednisolone as soon as the first cure in mild emetogenic chemotherapy. Groupe français d'étude de l'ondansétron].
    Coiffier B, Khayat D, Misset JL, Votan B.
    Bull Cancer; 1997 Aug; 84(8):781-7. PubMed ID: 9339181
    [Abstract] [Full Text] [Related]

  • 4. Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
    Gebbia V, Testa A, Cannata G, Gebbia N.
    Anticancer Drugs; 1996 Sep; 7(7):734-7. PubMed ID: 8949983
    [Abstract] [Full Text] [Related]

  • 5. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA, Lembersky B, Kaywin P, Kalman L, Yocom K, Friedman C.
    Cancer J Sci Am; 1998 Sep; 4(1):52-8. PubMed ID: 9467047
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Recent improvements in antiemetic therapy].
    Roila F, Palladino MA, Ciccarese G, Basurto C.
    Tumori; 1997 Sep; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [Abstract] [Full Text] [Related]

  • 9. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G, Macciò A, Bianchi A, Curreli L, Ghiani M, Proto E, Santona MC.
    Cancer; 1996 Mar 01; 77(5):941-8. PubMed ID: 8608488
    [Abstract] [Full Text] [Related]

  • 10. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Bonneterre J, Chevallier B, Metz R, Fargeot P, Pujade-Lauraine E, Spielmann M, Tubiana-Hulin M, Paes D, Bons J.
    J Clin Oncol; 1990 Jun 01; 8(6):1063-9. PubMed ID: 2140854
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A, Tripathi KD, Sharma M.
    Indian J Med Res; 2003 Jul 01; 118():33-41. PubMed ID: 14748464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
    Perez EA, Hesketh P, Sandbach J, Reeves J, Chawla S, Markman M, Hainsworth J, Bushnell W, Friedman C.
    J Clin Oncol; 1998 Feb 01; 16(2):754-60. PubMed ID: 9469367
    [Abstract] [Full Text] [Related]

  • 15. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1993 Dec 01; 11(12):2396-404. PubMed ID: 8246029
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
    Fanning J, Hilgers RD.
    Obstet Gynecol; 1994 Apr 01; 83(4):601-4. PubMed ID: 8134073
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemotherapy.
    Tsavaris N, Mylonakis N, Bacoyiannis C, Kosmas C, Kalergis G, Iakovidis V, Tzaninis D, Kosmidis P.
    Oncol Rep; 1998 Apr 01; 5(5):1147-55. PubMed ID: 9683826
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.